Search Results - "Baud'huin, M"

Sostdc1: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells by Faraahi, Z., Baud'huin, M., Croucher, P.I., Eaton, C., Lawson, M.A.

“…Multiple myeloma (MM) is characterised by destructive lytic bone disease, caused by induction of bone resorption and impaired bone formation. Our understanding…”
Get full text

Corrigendum to “Sostdc1: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells” [Bone 122 (May 2019) 82–92] by Faraahi, Z., Baud'huin, M., Croucher, P.I., Eaton, C., Lawson, M.A.

Get full text

Risk factors for failure of pre-cut eye bank UT-DSAEK grafts by Bodénès, F, Eude, Y, Baud'huin, M, Vabres, B, Weber, M, Le Meur, G, Orignac, I

“…The main risk factors for graft failure in penetrating keratoplasty are well known. However, few studies have examined donor characteristics or more precise…”
Get more information

Effects of a sulfated exopolysaccharide produced by Altermonas infernus on bone biology by Velasco, C Ruiz, Baud'huin, M, Sinquin, C, Maillasson, M, Heymann, D, Colliec-Jouault, S, Padrines, M

“…The growth and differentiation of bone cells is controlled by various factors, which can be modulated by heparan sulfates. Here, we investigated the effects of…”
Get full text

Key roles of the OPG-RANK-RANKL system in bone oncology by Baud huin, M, Duplomb, L, Velasco, C Ruiz, Fortun, Y, Heymann, D, Padrines, M

“…Osteoprotegerin (OPG)-receptor activator of nuclear factor- B (RANK) and RANK ligand (RANKL) have been identified as members of a ligand-receptor system that…”
Get full text

Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in rankl-induced osteoclastogenesis by Baud'huin, M, Renault, R, Charrier, C, Riet, A, Brion, R, Moreau, A, Gouin, F, Duplomb, L, Heymann, D

Get full text

Effects of a sulphated exopolysaccharide produced by alteromonas infernus on rat bone cells by Ruiz Velasco, C, Baud'huin, M, Duplomb, L, Colliec Jouault, S, Heymann, D, Padrines, M

Get full text

Confirming Variants in Next-Generation Sequencing Panel Testing by Sanger Sequencing by Baudhuin, Linnea M, Lagerstedt, Susan A, Klee, Eric W, Fadra, Numrah, Oglesbee, Devin, Ferber, Matthew J

“…Current clinical laboratory practice guidelines for next-generation sequencing (NGS) do not provide definitive guidance on confirming NGS variants. Sanger…”
Get full text

Glycosaminoglycans inhibit rankl-induced osteoclastogenesis by Baud'Huin, M, Ruiz Velasco, C, Jego, G, Charrier, C, Maillasson, M, Redini, F, Heymann, D, Duplomb, L

Get full text

The Dynamic and Multifaceted Nature of Cardiovascular Disease and Using Genetic Testing to Inform Clinical Care: An International Perspective by Baudhuin, Linnea M, De Backer, Julie, Ingles, Jodie, Milewicz, Dianna M, Tybjaerg-Hansen, Anne

Get full text

Decreased frequency of FBN1 missense variants in Ghent criteria-positive Marfan syndrome and characterization of novel FBN1 variants by Baudhuin, Linnea M, Kotzer, Katrina E, Lagerstedt, Susan A

“…The diagnosis of Marfan syndrome (MFS) remains challenging despite the 2010 revision to Ghent nosology criteria, and there is a lack of published information…”
Get full text

IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling by Saidi, S., Bouri, F., Lencel, P., Duplomb, L., Baud’huin, M., Delplace, S., Leterme, D., Miellot, F., Heymann, D., Hardouin, P., Palmer, G., Magne, D.

“…The aim of the present study was to investigate the potential role of the recently discovered IL-1 family member IL-33 in bone remodeling. Our results indicate…”
Get full text

UGT1A1 Genetic Analysis as a Diagnostic Aid for Individuals with Unconjugated Hyperbilirubinemia by Skierka, Jennifer M., BS, Kotzer, Katrina E., MS, Lagerstedt, Susan A., BS, O'Kane, Dennis J., PhD, Baudhuin, Linnea M., PhD

“…Objective To assess the clinical utility of UGT1A1 genetic testing and describe the spectrum and prevalence of UGT1A1 variations identified in pediatric…”
Get full text

What Is the True Prevalence of Hypertrophic Cardiomyopathy? by Baudhuin, Linnea M., PhD, Kotzer, Katrina E., MS, CGC, Kluge, Michelle L., MS, CGC, Maleszewski, Joseph J., MD

“…Technological advances have allowed us to more comprehensively and efficiently interrogate human genomes, and there are a number of large-scale efforts, such…”
Get full text

Prevalence and Spectrum of Large Deletions or Duplications in the Major Long QT Syndrome-Susceptibility Genes and Implications for Long QT Syndrome Genetic Testing by Tester, David J., BS, Benton, Amber J., BS, Train, Laura, BS, Deal, Barbara, MD, Baudhuin, Linnea M., PhD, Ackerman, Michael J., MD, PhD

“…Long QT syndrome (LQTS) is a cardiac channelopathy associated with syncope, seizures, and sudden death. Approximately 75% of LQTS is due to mutations in genes…”
Get full text

Determination of the Duplicated CYP2D6 Allele Using Real-Time PCR Signal: An Alternative Approach by Atiq, Mazen A, Peterson, Sandra E, Langman, Loralie J, Baudhuin, Linnea M, Black, John L, Moyer, Ann M

“…duplication has important pharmacogenomic implications. Reflex testing with long-range PCR (LR-PCR) can resolve the genotype when a duplication and alleles…”
Get full text

Hypertrophic Cardiomyopathy in the General Population: Leveraging the UK Biobank Database and Machine Learning Phenotyping by Baudhuin, Linnea M

Get full text

Sphingosylphosphorylcholine and Lysophosphatidylcholine Are Ligands for the G Protein-coupled Receptor GPR4 by Zhu, Kui, Baudhuin, Linnea M., Hong, Guiying, Williams, Freager S., Cristina, Kelly L., Kabarowski, Janusz H.S., Witte, Owen N., Xu, Yan

“…Sphingosylphosphorylcholine (SPC) and lysophosphatidylcholine (LPC) are bioactive lipid molecules involved in numerous biological processes. We have recently…”
Get full text

Genomics Integration Into Nephrology Practice by Pinto e Vairo, Filippo, Prochnow, Carri, Kemppainen, Jennifer L., Lisi, Emily C., Steyermark, Joan M., Kruisselbrink, Teresa M., Pichurin, Pavel N., Dhamija, Rhadika, Hager, Megan M., Albadri, Sam, Cornell, Lynn D., Lazaridis, Konstantinos N., Klee, Eric W., Senum, Sarah R., El Ters, Mireille, Amer, Hatem, Baudhuin, Linnea M., Moyer, Ann M., Keddis, Mira T., Zand, Ladan, Sas, David J., Erickson, Stephen B., Fervenza, Fernando C., Lieske, John C., Harris, Peter C., Hogan, Marie C.

“…The etiology of kidney disease remains unknown in many individuals with chronic kidney disease (CKD). We created the Mayo Clinic Nephrology Genomics Clinic to…”
Get full text

RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases by Baud'huin, M, Lamoureux, F, Duplomb, L, Rédini, F, Heymann, D

“…1997 saw the identification of a novel set of proteins within the tumor necrosis factor (TNF)/TNF receptor families that are required for the control of bone…”
Get full text